Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE: 002332)
China
· Delayed Price · Currency is CNY 12.59
-0.19 (-1.49%)
Nov 14, 2024, 3:04 PM CST
Zhejiang Xianju Pharmaceutical Co.,Ltd. Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 621.66 | 563.08 | 749.41 | 619.33 | 504.51 | 410.37 | Upgrade
|
| Depreciation & Amortization | 216.8 | 216.8 | 193 | 189.52 | 177.11 | 135.12 | Upgrade
|
| Other Amortization | 4.38 | 4.38 | 2.74 | 4.32 | 3.19 | 14.86 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.48 | 1.48 | -91.62 | -14.51 | 0.74 | 0.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.42 | 0.42 | 0.91 | 1.68 | 1.12 | 13.6 | Upgrade
|
| Loss (Gain) From Sale of Investments | 7.17 | 7.17 | -49.35 | -29.22 | -6.12 | -14.74 | Upgrade
|
| Provision & Write-off of Bad Debts | -7.29 | -7.29 | 4 | - | -8.83 | 18.63 | Upgrade
|
| Other Operating Activities | -287.75 | 42.53 | 32.38 | 25.45 | 121.56 | 117.53 | Upgrade
|
| Change in Accounts Receivable | -203.22 | -203.22 | -129.77 | 69.04 | 3.3 | -168.92 | Upgrade
|
| Change in Inventory | -105.98 | -105.98 | -92.65 | -233.44 | -106.04 | -63.89 | Upgrade
|
| Change in Accounts Payable | 69.36 | 69.36 | -9.79 | 24.19 | 94.98 | 52.25 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | - | 9.57 | Upgrade
|
| Operating Cash Flow | 323.78 | 595.48 | 609.28 | 657.9 | 789.23 | 519.81 | Upgrade
|
| Operating Cash Flow Growth | -55.78% | -2.27% | -7.39% | -16.64% | 51.83% | 168.96% | Upgrade
|
| Capital Expenditures | -251.7 | -234.63 | -282.54 | -248.58 | -118.17 | -262.34 | Upgrade
|
| Sale of Property, Plant & Equipment | 48.04 | 1.31 | 4.03 | 37.74 | 1.41 | 7.56 | Upgrade
|
| Divestitures | -1.78 | 48.22 | 69.88 | - | - | 16.04 | Upgrade
|
| Investment in Securities | -24.63 | -16.33 | 507.04 | 6.53 | -478.37 | -33.84 | Upgrade
|
| Other Investing Activities | 2.21 | 4.81 | 59.67 | -0.38 | 20.55 | 61.22 | Upgrade
|
| Investing Cash Flow | -227.86 | -196.63 | 358.07 | -204.68 | -574.59 | -211.36 | Upgrade
|
| Long-Term Debt Issued | - | 1.36 | 198.15 | 433.79 | 892.34 | 1,098 | Upgrade
|
| Long-Term Debt Repaid | - | -158.86 | -584.73 | -808.94 | -1,504 | -1,102 | Upgrade
|
| Net Debt Issued (Repaid) | -178.99 | -157.5 | -386.58 | -375.16 | -611.73 | -4.47 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 990 | - | Upgrade
|
| Common Dividends Paid | -298.03 | -299.77 | -154.22 | -172.13 | -142.39 | -115.99 | Upgrade
|
| Other Financing Activities | -5.08 | -6.58 | 118.36 | 63.15 | 74.04 | -46.18 | Upgrade
|
| Financing Cash Flow | -482.1 | -463.85 | -422.44 | -484.13 | 309.92 | -166.65 | Upgrade
|
| Foreign Exchange Rate Adjustments | -34.29 | -13.44 | 28.17 | -32.71 | -28.31 | 1.3 | Upgrade
|
| Net Cash Flow | -420.47 | -78.43 | 573.09 | -63.64 | 496.25 | 143.1 | Upgrade
|
| Free Cash Flow | 72.08 | 360.85 | 326.74 | 409.31 | 671.06 | 257.46 | Upgrade
|
| Free Cash Flow Growth | -85.37% | 10.44% | -20.17% | -39.01% | 160.64% | 972.25% | Upgrade
|
| Free Cash Flow Margin | 1.75% | 8.75% | 7.46% | 9.39% | 16.70% | 6.94% | Upgrade
|
| Free Cash Flow Per Share | 0.07 | 0.37 | 0.33 | 0.41 | 0.73 | 0.28 | Upgrade
|
| Cash Income Tax Paid | 303.03 | 286.67 | 423.25 | 380.93 | 251.79 | 285.69 | Upgrade
|
| Levered Free Cash Flow | 6.25 | 389.58 | 279.35 | 310.37 | 506.72 | 253.71 | Upgrade
|
| Unlevered Free Cash Flow | 7.62 | 391.68 | 283.28 | 324.81 | 537.49 | 291.11 | Upgrade
|
| Change in Net Working Capital | 387.13 | -27.14 | 54.17 | 41.02 | -75.34 | -52.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.